posted on 2021-05-06, 20:29authored byKarina Vega-Granados, Marta Medina-O’Donnell, Francisco Rivas, Fernando J. Reyes-Zurita, Antonio Martinez, Luis Alvarez de Cienfuegos, Jose A. Lupiañez, Andres Parra
A set of 12 maslinic acid–coumarin
conjugates was synthesized,
with 9 being maslinic acid–diamine–coumarin conjugates
at the C-28 carboxylic acid group of triterpene acid and the other
three being maslinic acid–coumarin conjugates at C-2/C-3 and/or
C-28 of the triterpene skeleton. The cytotoxic effects of these 12
triterpene conjugates were evaluated in three cancer cell lines (B16-F10,
HT29, and Hep G2) and compared, respectively, with three nontumor
cell lines from the same or similar tissue (HPF, IEC-18, and WRL68).
The most potent cytotoxic results were achieved by a conjugate with
two molecules of coumarin-3-carboxylic acid coupled through the C-2
and C-3 hydroxy groups of maslinic acid. This conjugate showed submicromolar
IC50 values in two of the three cancer cell lines tested
(0.6, 1.1, and 0.9 μM), being between 110- and 30-fold more
effective than its corresponding precursor. Furthermore, this conjugate
(10) showed percentages of cell viability for the three
nontumor lines of 90%. Four maslinic acid–coumarin conjugates
displayed apoptotic effects in the treated cells, with total apoptosis
rates of between 40 and 85%, relative to the control. Almost all the
compounds assayed caused cell-cycle arrest in all cancer cell lines,
increasing the number of these cells in the G0/G1 phase.